Insulet | PODD - Spese Di Vendita E Di Amministrazione

Prezzo Delle Azioni
199.33
Cambio Giornaliero
-4.18 -2.05%
Mensile
-16.33%
Annuale
-20.73%
Q2 Previsione
198.16




Spese Di Vendita E Di Amministrazione Cambiamento Data
Abbott USD 3.13B 125M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
AtriCure USD 78.34M 109K 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Cardinal Health USD 1.5B 43M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Globus Medical USD 318.48M 4.88M 2025-12
ICU Medical USD 155.81M 3.04M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
J&J USD 6.75B 831M 2025-12
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Solventum Corp USD 759M 15M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
West Pharmaceutical Services USD 106.5M 3.8M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12